BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34086013)

  • 1. Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
    Khalighinejad P; Parrott D; Jordan VC; Chirayil S; Preihs C; Rofsky NM; Xi Y; Sherry AD
    Invest Radiol; 2021 Jul; 56(7):450-457. PubMed ID: 34086013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer.
    Chatterjee A; Gallan AJ; He D; Fan X; Mustafi D; Yousuf A; Antic T; Karczmar GS; Oto A
    Abdom Radiol (NY); 2019 Jun; 44(6):2233-2243. PubMed ID: 30955071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide Proton Transfer Could Provide More Accurate Lesion Characterization in the Transition Zone of the Prostate.
    Guo Z; Qin X; Mu R; Lv J; Meng Z; Zheng W; Zhuang Z; Zhu X
    J Magn Reson Imaging; 2022 Nov; 56(5):1311-1319. PubMed ID: 35429190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia.
    Sommer G; Pauly KB; Holbrook A; Plata J; Daniel B; Bouley D; Gill H; Prakash P; Salgaonkar V; Jones P; Diederich C
    Invest Radiol; 2013 Jun; 48(6):387-94. PubMed ID: 23462673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchrotron Radiation X-ray Fluorescence Elemental Mapping in Healthy versus Malignant Prostate Tissues Provides New Insights into the Glucose-Stimulated Zinc Trafficking in the Prostate As Discovered by MRI.
    Clavijo Jordan V; Al-Ebraheem A; Geraki K; Dao E; Martins AF; Chirayil S; Farquharson M; Sherry AD
    Inorg Chem; 2019 Oct; 58(20):13654-13660. PubMed ID: 31260276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?
    Walton Diaz A; Hoang AN; Turkbey B; Hong CW; Truong H; Sterling T; Rais-Bahrami S; Siddiqui MM; Stamatakis L; Vourganti S; Nix J; Logan J; Harris C; Weintraub M; Chua C; Merino MJ; Choyke P; Wood BJ; Pinto PA
    J Urol; 2013 Dec; 190(6):2020-2025. PubMed ID: 23792130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IVIM-DKI for differentiation between prostate cancer and benign prostatic hyperplasia: comparison of 1.5 T vs. 3 T MRI.
    Malagi AV; Netaji A; Kumar V; Baidya Kayal E; Khare K; Das CJ; Calamante F; Mehndiratta A
    MAGMA; 2022 Aug; 35(4):609-620. PubMed ID: 34052899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.
    Li B; Xu A; Wang N; Min X; Feng Z; Deng M; Li L; Cai J; Kang Z; Jiang K; Kuang D; Wang L
    J Magn Reson Imaging; 2017 Oct; 46(4):1220-1229. PubMed ID: 28182304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
    Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imaging.
    Klingebiel M; Ullrich T; Quentin M; Bonekamp D; Aissa J; Mally D; Arsov C; Albers P; Antoch G; Schimmöller L
    Eur J Radiol; 2020 Sep; 130():109161. PubMed ID: 32650128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between prostate size and glandular tissue volume of the peripheral zone via novel combined MRI and histopathology: possible pathophysiological implications on prostate cancer development.
    Lin B; Cavdar IK; Buxton M; Sellers J; Brandi L; Helo N; de Riese WTW
    Int Urol Nephrol; 2023 Apr; 55(4):835-844. PubMed ID: 36739353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    Wu M; Krishna S; Thornhill RE; Flood TA; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Sep; 50(3):940-950. PubMed ID: 30701625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study.
    Xin JY; Gao SS; Liu JG; Sun CF; Han Y; Sun XH; Wang XZ; Wang B
    Magn Reson Imaging; 2017 Dec; 44():26-31. PubMed ID: 28782677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging.
    Xing P; Chen L; Yang Q; Song T; Ma C; Grimm R; Fu C; Wang T; Peng W; Lu J
    Cancer Imaging; 2021 Sep; 21(1):54. PubMed ID: 34579789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-enhanced MRI of the abnormal prostate.
    Sommer FG; Nghiem HV; Herfkens R; McNeal J
    Magn Reson Imaging; 1993; 11(7):941-8. PubMed ID: 7694028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer.
    Asbach P; Ro SR; Aldoj N; Snellings J; Reiter R; Lenk J; Köhlitz T; Haas M; Guo J; Hamm B; Braun J; Sack I
    Invest Radiol; 2020 Aug; 55(8):524-530. PubMed ID: 32496317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.